Senior Director, Medical Affairs Strategy & Launch--Hematology

Sumitomo Pharma•Marlborough, MA

2d•Remote

About The Position

The Senior Director, Medical Strategy, Hematologic Malignancies & Launch Readiness is an individual contributor on the Medical Affairs team, reporting to the VP of Medical Affairs. The role supports development and execution of medical affairs launch strategies for investigational assets and medical strategies for marketed hematology-oncology assets. It provides scientific and strategic leadership by integrating external insights, clinical evidence, disease-state knowledge, and cross-functional perspectives across the product lifecycle. A focus on acute leukemias and myeloproliferative neoplasms is preferred. The role works across Field Medical, Clinical Development, Medical Communications, HEOR/RWE, Medical Information, Commercial, Regulatory, and other internal teams to coordinate evidence generation, scientific exchange, and stakeholder engagement. It supports medical planning and launch readiness, develops scientific platforms and core medical messages, contributes to evidence-generation and publication strategies, and ensures activities meet applicable legal, regulatory, company, and industry requirements. This is a primarily remote role with periodic on-site office meetings and domestic and international travel as needed. Travel is approximately 30–50%. The role involves a fast-paced environment, multiple demands, independent judgment and initiative, frequent computer use, and strong written and oral communication. There are no direct reports or formal people-management responsibilities. The base salary range is $247,400–$309,200. The total rewards package includes the opportunity for merit-based salary increases, short incentive plan participation, 401(k), medical, dental, vision, life and disability insurance, and leaves provided in line with the employee’s work state. Time off includes flexible paid time off, 11 paid holidays plus a year-end shutdown period, and 80 hours of paid sick time upon hire and annually thereafter.

Requirements

Advanced scientific or clinical degree required: PharmD, PhD, MD, DO, DNP, or equivalent.
At least 12 years of relevant experience in the biotech or pharmaceutical industry.
At least 7 years of Medical Affairs experience in oncology and/or hematology.
Demonstrated experience developing and executing medical strategies.
Strong knowledge of hematologic malignancies, clinical research, and evidence generation.
Experience engaging with KOLs, investigators, and external stakeholders.
Excellent communication, presentation, and scientific storytelling skills.
Strong project management and cross-functional leadership capabilities.
Advanced knowledge of hematologic malignancy biology, treatment paradigms, biomarkers, and emerging therapeutic approaches.
Strong understanding of drug development, clinical research, Medical Affairs functions, and evidence-generation methodologies.
Knowledge of healthcare systems, scientific publication practices, and external stakeholder engagement strategies.
Understanding of pharmaceutical regulations, compliance requirements, and industry codes governing Medical Affairs.
Ability to translate scientific and competitive insights into actionable strategies and evaluate clinical, scientific, and real-world evidence.
Ability to lead and influence cross-functional teams without direct authority and work effectively in a matrixed, fast-paced environment.
Ability to identify evidence gaps, synthesize complex information and perspectives, and make strategic recommendations.
Ability to maintain high ethical standards and comply with applicable regulations and company policies.
Ability to travel approximately 30–50%, including domestic and international travel as needed.
Ability to use a personal computer for extended periods.

Nice To Haves

MD or PharmD degree preferred.
Strong focus or experience in acute leukemias and myeloproliferative neoplasms preferred.

Responsibilities

Support development and implementation of comprehensive Medical Affairs strategies for hematologic malignancy assets and disease areas.
Contribute to annual medical planning, strategic imperatives, and tactical activities aligned with corporate objectives.
Monitor scientific, clinical, and competitive landscapes and translate insights into actionable medical strategies.
Represent Medical Affairs on cross-functional product and launch teams.
Build and maintain scientific relationships with key opinion leaders, investigators, professional societies, and patient advocacy organizations.
Lead external advisory boards and scientific exchange activities to gather insights that inform strategy.
Represent Medical Affairs at scientific congresses, hematology meetings, and other external scientific forums.
Provide scientific leadership for disease-state education and stakeholder engagement initiatives.
Partner with Clinical Development, HEOR, and RWE teams to identify evidence gaps and support data-generation strategies.
Contribute to investigator-sponsored research strategy, scientific review, and oversight.
Support publication plans and scientific dissemination strategies.
Synthesize insights from field interactions, advisory boards, congresses, and stakeholder engagements to refine strategy and tactical execution.
Support launch readiness planning and execution for pipeline and marketed hematology assets.
Develop scientific platforms and core medical messages communicating clinical value, differentiation, and unmet need.
Partner with Medical Communications and Training to support scientific consistency in medical materials and field resources.
Identify opportunities to strengthen asset differentiation through evidence generation and stakeholder engagement.
Provide strategic medical input into congress planning, educational initiatives, and stakeholder engagement activities.
Ensure activities comply with applicable laws, regulations, company policies, and industry standards.
Travel to scientific meetings, congresses, advisory boards, investigator meetings, and field engagements as business needs require.